A M Gröger

577 total citations
10 papers, 511 citations indexed

About

A M Gröger is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, A M Gröger has authored 10 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in A M Gröger's work include Neuroblastoma Research and Treatments (3 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer-related Molecular Pathways (2 papers). A M Gröger is often cited by papers focused on Neuroblastoma Research and Treatments (3 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer-related Molecular Pathways (2 papers). A M Gröger collaborates with scholars based in United States, Italy and Austria. A M Gröger's co-authors include Feliciano Baldi, Vincenzo Esposito, Alfonso Baldi, M Caputi, Antonio Giordano, Antonio De Luca, Michele Pagano, Massimo Loda, Giovan Giacomo Giordano and Stuart E. Siegel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Handchirurgie · Mikrochirurgie · Plastische Chirurgie and PubMed.

In The Last Decade

A M Gröger

10 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A M Gröger United States 6 383 273 99 60 56 10 511
Eiichi Tahara Japan 14 304 0.8× 441 1.6× 88 0.9× 106 1.8× 92 1.6× 17 729
Neelam G. Shah India 13 338 0.9× 225 0.8× 69 0.7× 102 1.7× 118 2.1× 23 591
Yumiko Shinohe Japan 9 168 0.4× 166 0.6× 55 0.6× 72 1.2× 38 0.7× 11 336
Dao Doan United States 7 179 0.5× 250 0.9× 71 0.7× 67 1.1× 26 0.5× 11 437
A J Klein-Szanto United States 9 208 0.5× 291 1.1× 98 1.0× 94 1.6× 43 0.8× 10 571
Junko Matsuoka Japan 11 371 1.0× 377 1.4× 120 1.2× 230 3.8× 84 1.5× 25 692
Kelly Foley United States 10 357 0.9× 335 1.2× 54 0.5× 124 2.1× 30 0.5× 14 695
Shingo Tamura Japan 12 285 0.7× 284 1.0× 84 0.8× 63 1.1× 72 1.3× 38 578
Jonathan H. Law United States 6 230 0.6× 184 0.7× 65 0.7× 95 1.6× 50 0.9× 7 439
Fumitake Kai Japan 10 231 0.6× 220 0.8× 117 1.2× 100 1.7× 58 1.0× 19 436

Countries citing papers authored by A M Gröger

Since Specialization
Citations

This map shows the geographic impact of A M Gröger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Gröger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Gröger more than expected).

Fields of papers citing papers by A M Gröger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M Gröger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Gröger. The network helps show where A M Gröger may publish in the future.

Co-authorship network of co-authors of A M Gröger

This figure shows the co-authorship network connecting the top 25 collaborators of A M Gröger. A scholar is included among the top collaborators of A M Gröger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M Gröger. A M Gröger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gröger, A M, et al.. (2008). Das Merkel-Zell-Karzinom und Immunsuppression: Drei Fallberichte und Überblick der therapeutischen Optionen. Handchirurgie · Mikrochirurgie · Plastische Chirurgie. 40(2). 105–109. 1 indexed citations
2.
Baldi, Alfonso, et al.. (2000). Neuroendocrine differentiation in non-small cell lung carcinomas.. PubMed. 14(1). 109–14. 17 indexed citations
3.
Caputi, M, Vincenzo Esposito, A M Gröger, et al.. (1998). Prognostic role of proliferating cell nuclear antigen in lung cancer: an immunohistochemical analysis.. PubMed. 12(1). 85–8. 8 indexed citations
4.
Caputi, M, Vincenzo Esposito, A M Gröger, et al.. (1998). RB growth control evasion in lung cancer.. PubMed. 18(4A). 2371–4. 3 indexed citations
5.
Bödey, B, A M Gröger, James V. Luck, et al.. (1997). Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.. PubMed. 17(2B). 1319–30. 57 indexed citations
6.
Esposito, Vincenzo, Alfonso Baldi, Antonio De Luca, et al.. (1997). Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.. PubMed. 57(16). 3381–5. 381 indexed citations
7.
Esposito, Vincenzo, Alfonso Baldi, Antonio De Luca, et al.. (1997). Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerations.. PubMed. 17(1B). 601–4. 4 indexed citations
8.
Bödey, B, A M Gröger, Stuart E. Siegel, & H. E. Kaiser. (1997). Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.. PubMed. 17(2A). 1187–94. 6 indexed citations
9.
Bödey, B, A M Gröger, Stuart E. Siegel, & H. E. Kaiser. (1997). Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.. PubMed. 17(1A). 189–96. 5 indexed citations
10.
Mägert, Hans‐Jürgen, Thorsten Hadrys, Alexandra Cieslak, et al.. (1995). cDNA sequence and expression pattern of the putative pheromone carrier aphrodisin.. Proceedings of the National Academy of Sciences. 92(6). 2091–2095. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026